US equities
|
NVDA
$155.46
▲+0.00%
MU
$712.42
▲+0.00%
SNDK
$797.24
▲+0.00%
AMD
$503.41
▲+0.00%
AES
$14.97
▲+0.00%
SPCX
$141.70
▲+0.00%
NBIS
$106.03
▼-0.00%
SKHY
$122.61
▲+0.00%
NVDA
$155.46
▲+0.00%
MU
$712.42
▲+0.00%
SNDK
$797.24
▲+0.00%
AMD
$503.41
▲+0.00%
AES
$14.97
▲+0.00%
SPCX
$141.70
▲+0.00%
NBIS
$106.03
▼-0.00%
SKHY
$122.61
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Phase 2
Recent news which mentions Phase 2
Marker Therapeutics Secures $13.1M Grant To Support MultiTAA Cell Therapy Trial
August 20, 2021
Tickers
MRKR
Tags
News
Trading Ideas
MRKR
From
Benzinga
Paratek's Antibiotic Gets FDA Orphan Drug Tag For Lung Infection
August 19, 2021
Tickers
PRTK
Tags
antibiotics
Orphan Drug Designation
Benzinga
From
Benzinga
Galecto Starts Dosing In Mid-Stage Myelofibrosis Trial
August 18, 2021
Tickers
GLTO
Tags
GLTO
myelofibrosis
Market News
From
Benzinga
DMC Recommends Biophytis Continue Sarconeos COVID-19 Study
August 16, 2021
Tickers
BPTS
Tags
BPTS
Benzinga
Biotech
From
Benzinga